Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Novo Nordisk Has a Fresh New Name -- but It Still Faces the Same Old Problems

Key PointsNovo Nordisk is in the middle of an important product launch, as it rolls out a pill version of its GLP-1 drug.

We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at nasdaq.com →

More in Finance & Markets

More from Tuesday 22 September →